South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years
The South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthSouth African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years
View Premium plansBrowse free archive reportsThe South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years.